PDX Pharmaceuticals
Manufacturing · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3303 S Bond Ave, Portland, Oregon, 97239...Phone Number
(503) 418-0483Website
www.pdxpharm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About PDX Pharmaceuticals
PDX Pharmaceuticals, also known as Raksa Therapeutics, is a biopharmaceutical company focused on developing innovative nanotherapeutic pipelines to enhance cancer-specific immunity. The company utilizes its proprietary nanoparticle platform to create next-generation combination immunotherapies for various types of cancer, including lung and breast cancer. PDX is currently conducting IND enabling studies for its drug candidates, ARAC-02 and AIRISE-02, with plans to initiate clinical trials by 2025. Their target clients include healthcare providers and patients seeking advanced cancer treatment options.Explore more
PDX Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PDX Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once PDX Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when PDX Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at PDX Pharmaceuticals
Check out if PDX Pharmaceuticals is spiking on competitors!
Click to see if PDX Pharmaceuticals had a recent Job posting/layoffs
Check if PDX Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on PDX Pharmaceuticals recently announced quarterly report
PDX Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined PDX Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to PDX Pharmaceuticals
Compare insights from companies similar to PDX Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PDX Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PDX Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PDX Pharmaceuticals.
PDX Pharmaceuticals financials insights
Gather financial insights about PDX Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$92K
PDX Pharmaceuticals Tech Stack
A closer look at the technologies used by PDX Pharmaceuticals
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Award, Spending/Investment, Search, Medical Research, Clinical Operations, Operations
Funding
Project
Award, Spending/Investment
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PDX Pharmaceuticals
Sign Up For FreeTo access detailed company insights
PDX Pharmaceuticals, also known as Raksa Therapeutics, is a biopharmaceutical company focused on developing innovative nanotherapeutic pipelines to enhance cancer-specific immunity. The company utilizes its proprietary nanoparticle platform to create next-generation combination immunotherapies for various types of cancer, including lung and breast... Read More
